{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:33:42Z","timestamp":1767414822712,"version":"3.48.0"},"reference-count":13,"publisher":"Society for Clinical Epidemiology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Clin Epidemiol","ACE"],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.37737\/ace.26002","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:07:37Z","timestamp":1750356457000},"page":"10-17","source":"Crossref","is-referenced-by-count":0,"title":["Overview of Immunotherapy Administration for Miller Fisher Syndrome in Japan: A Nationwide Retrospective Cohort Study"],"prefix":"10.37737","volume":"8","author":[{"given":"Satoshi","family":"Kodama","sequence":"first","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo"},{"name":"Department of Neurology, University of Iowa Hospital and Clinics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Kainaga","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Aso","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Save Sight Institute, The Faculty of Medicine and Health, The University of Sydney"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Shirota","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo"},{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Informatics, Institute of Science Tokyo Graduate School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsushi","family":"Toda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24670","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mori M, Kuwabara S. Fisher syndrome. Curr Treat Options Neurol 2011;13:71\u201378.","DOI":"10.1007\/s11940-010-0103-8"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001;56:1104\u20131106.","DOI":"10.1212\/WNL.56.8.1104"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology 2007;68:1144\u20131146.","DOI":"10.1212\/01.wnl.0000258673.31824.61"},{"key":"4","unstructured":"4. Japanese Society of Neurology. Practical guideline for Guillain barre syndrome and Fisher syndrome 2013. Tokyo: Nankodo Co, Ltd; 2013."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sekiguchi Y, Mori M, Misawa S, Sawai S, Yuki N, Beppu M, et al. How often and when Fisher syndrome is overlapped by Guillain\u2013Barr\u00e9 syndrome or Bickerstaff brainstem encephalitis? Eur J Neurol 2016;23:1058\u20131063.","DOI":"10.1111\/ene.12983"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Verboon C, van Berghem H, van Doorn PA, Ruts L, Jacobs BC. Prediction of disease progression in Miller Fisher and overlap syndromes. J Peripher Nerv Syst 2017;22:446\u2013450.","DOI":"10.1111\/jns.12238"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gold R, Stangel M, Dalakas MC. Drug Insight: the use of intravenous immunoglobulin in neurology\u2014therapeutic considerations and practical issues. Nat Clin Pract Neurol 2007;3:36\u201344.","DOI":"10.1038\/ncpneuro0376"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yasunaga H, Matsui H, Horiguchi H, Fushimi K, Matsuda S. Clinical epidemiology and health services research using the diagnosis procedure combination database in Japan. Asian Pac J Dis Manag 2015;7:19\u201324 (in Japanese).","DOI":"10.7223\/apjdm.7.19"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamana H, Matsui H, Sasabuchi Y, Fushimi K, Yasunaga H. Categorized diagnoses and procedure records in an administrative database improved mortality prediction. J Clin Epidemiol 2015;68:1028\u20131035.","DOI":"10.1016\/j.jclinepi.2014.12.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol 2017;27:476\u2013482.","DOI":"10.1016\/j.je.2016.09.009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakajima M, Okada Y, Sonoo T, Goto T. Development and validation of a novel method for converting the Japan Coma Scale to Glasgow Coma Scale. J Epidemiol 2023;33:531\u2013535.","DOI":"10.2188\/jea.JE20220147"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Shigematsu K, Nakano H, Watanabe Y. The eye response test alone is sufficient to predict stroke outcome\u2014reintroduction of Japan Coma Scale: a cohort study. BMJ Open 2013;3:e002736.","DOI":"10.1136\/bmjopen-2013-002736"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Roth K, Darwish C, Keller MD, Hammer B, Ahmed-Winston S, Escalante E, et al. Implementation of a tier system for IVIG indications to address IVIG shortage at a tertiary care pediatric medical center. Pediatr Blood Cancer 2024;71:e30871.","DOI":"10.1002\/pbc.30871"}],"container-title":["Annals of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ace\/8\/1\/8_26002\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:28:55Z","timestamp":1767414535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ace\/8\/1\/8_26002\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.37737\/ace.26002","relation":{},"ISSN":["2434-4338"],"issn-type":[{"type":"electronic","value":"2434-4338"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"26002"}}